Related Experiment Video
Updated: Oct 19, 2026
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Hepatitis C. Diagnostic and prognostic aspects from the insurance medicine viewpoint]
1Schweizerischen Rückversicherungs-Gesellschaft, Zürich.
Insights
Hepatitis C (HCV) is a silent chronic infection often diagnosed incidentally. Prognosis assessment requires careful consideration of long-term follow-up data beyond initial treatment response.
Area of Science:
- Hepatology and Viral Infections
- Epidemiology and Public Health
- Clinical Diagnostics and Prognostics
Context:
- Hepatitis C virus (HCV) infection is typically chronic and asymptomatic, complicating diagnosis and epidemiological studies.
- Incidental diagnosis through routine screening or elevated liver enzymes is common, highlighting the silent nature of the disease.
- Interpreting prevalence and incidence data requires careful consideration of potential biases in epidemiological studies.
Purpose:
- To address the challenges in assessing Hepatitis C prognosis due to its asymptomatic course and data limitations.
- To emphasize the need for caution in epidemiological study interpretation and underwriting guidelines.
- To highlight the importance of long-term follow-up for accurate prognosis evaluation.
Summary:
- Hepatitis C often presents without acute symptoms, making early diagnosis difficult and impacting epidemiological data accuracy.
- Assessing long-term effects and prognosis is challenging due to small study cohorts, potential selection bias, and unknown viral loads.
- Diagnostic test availability may lead to anti-selection, necessitating careful underwriting guidelines based on well-documented cases.
Impact:
- Underscores the need for robust methodologies in Hepatitis C research to mitigate bias in prevalence and incidence data.
- Recommends a 2-year follow-up period post-therapy to provide more reliable prognostic information than treatment response alone.
- Informs clinical practice and insurance underwriting by stressing the limitations of current prognostic indicators for Hepatitis C.
Abstract:
Hepatitis C is a chronic infection with potentially serious long-term effects. An acute clinical presentation is the exception, often the disease is only diagnosed through routine screening (e.g. as a blood donor) or work-up for elevated liver enzymes. The silent course of this disease also makes it difficult to interpret epidemiological studies. Potential biases need to be considered which may lead to underestimation or overestimation of prevalence and incidence data. Special attention is needed in evaluating long-term effects as the studies usually deal with small numbers of HCV positives and their selection may not have been randomised. An assessment of the prognosis is difficult, especially in the absence of a series of liver enzyme measurements and if the viral load is unknown. The wide availability of diagnostic tests harbours a potential for anti-selection. Caution is therefore required when designing underwriting guidelines; only well documented cases should be accepted. A response to therapy (e.g. with interferon), alone, does not prove a good prognosis, rather, the course over a 2-year follow-up may give relevant prognostic information.
Related Concept Videos
01:25Hepatitis
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:24Cirrhosis II: Pathophysiology
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:28Viral Hepatitis I: Introduction
01:23Cirrhosis I: Introduction